366 related articles for article (PubMed ID: 16474176)
1. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Knuutila S; Lundán T; Mannermaa A; Børresen-Dale AL; Borg A; Barkardottir RB; Petrini J; Winqvist R
Carcinogenesis; 2006 Aug; 27(8):1593-9. PubMed ID: 16474176
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
3. Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
Bartkova J; Tommiska J; Oplustilova L; Aaltonen K; Tamminen A; Heikkinen T; Mistrik M; Aittomäki K; Blomqvist C; Heikkilä P; Lukas J; Nevanlinna H; Bartek J
Mol Oncol; 2008 Dec; 2(4):296-316. PubMed ID: 19383352
[TBL] [Abstract][Full Text] [Related]
4. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
He M; Di GH; Cao AY; Hu Z; Jin W; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 May; 133(1):111-6. PubMed ID: 21811815
[TBL] [Abstract][Full Text] [Related]
5. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
6. Haplotypic variation in MRE11, RAD50 and NBS1 and risk of non-Hodgkin's lymphoma.
Rollinson S; Kesby H; Morgan GJ
Leuk Lymphoma; 2006 Dec; 47(12):2567-83. PubMed ID: 17169801
[TBL] [Abstract][Full Text] [Related]
7. Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia.
Mosor M; Ziółkowska-Suchanek I; Nowicka K; Dzikiewicz-Krawczyk A; Januszkiewicz-Lewandowska D; Nowak J
BMC Cancer; 2013 Oct; 13():457. PubMed ID: 24093751
[TBL] [Abstract][Full Text] [Related]
8. Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
Uhrhammer N; Delort L; Bignon YJ
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):684-5. PubMed ID: 19190165
[TBL] [Abstract][Full Text] [Related]
9. The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.
Alemayehu A; Fridrichova I
Eur J Hum Genet; 2007 Sep; 15(9):922-9. PubMed ID: 17534377
[TBL] [Abstract][Full Text] [Related]
10. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
Dzikiewicz-Krawczyk A
Mutat Res; 2008; 659(3):262-73. PubMed ID: 18606567
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
Allen-Brady K; Camp NJ
BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
[TBL] [Abstract][Full Text] [Related]
13. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
Rebbeck TR; Mitra N; Domchek SM; Wan F; Chuai S; Friebel TM; Panossian S; Spurdle A; Chenevix-Trench G; ; Singer CF; Pfeiler G; Neuhausen SL; Lynch HT; Garber JE; Weitzel JN; Isaacs C; Couch F; Narod SA; Rubinstein WS; Tomlinson GE; Ganz PA; Olopade OI; Tung N; Blum JL; Greenberg R; Nathanson KL; Daly MB
Cancer Res; 2009 Jul; 69(14):5801-10. PubMed ID: 19584272
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.
Schuetz JM; MaCarthur AC; Leach S; Lai AS; Gallagher RP; Connors JM; Gascoyne RD; Spinelli JJ; Brooks-Wilson AR
BMC Med Genet; 2009 Nov; 10():117. PubMed ID: 19917125
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of RAD50 in familial breast cancer predisposition.
Tommiska J; Seal S; Renwick A; Barfoot R; Baskcomb L; Jayatilake H; Bartkova J; Tallila J; Kaare M; Tamminen A; Heikkilä P; Evans DG; Eccles D; Aittomäki K; Blomqvist C; Bartek J; Stratton MR; Nevanlinna H; Rahman N
Int J Cancer; 2006 Jun; 118(11):2911-6. PubMed ID: 16385572
[TBL] [Abstract][Full Text] [Related]
16. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
17. Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.
Cao AY; Hu Z; Yin WJ; Jin W; Shao ZM
Breast Cancer Res Treat; 2010 May; 121(1):247-9. PubMed ID: 19904603
[No Abstract] [Full Text] [Related]
18. RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer.
Gao J; Zhang H; Arbman G; Sun XF
Histol Histopathol; 2008 Dec; 23(12):1495-502. PubMed ID: 18830935
[TBL] [Abstract][Full Text] [Related]
19. Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies.
Aloraifi F; McCartan D; McDevitt T; Green AJ; Bracken A; Geraghty J
Cancer Genet; 2015 Sep; 208(9):455-63. PubMed ID: 26250988
[TBL] [Abstract][Full Text] [Related]
20. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.
Debniak T; Górski B; Cybulski C; Jakubowska A; Kurzawski G; Lener M; Mierzejewski M; Masojć B; Medrek K; Kładny J; Załuga E; Maleszka R; Chosia M; Lubiński J
Melanoma Res; 2003 Aug; 13(4):365-70. PubMed ID: 12883362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
